Technology Innovation

The Facts

  • Skin cancer incidence is continuing to increase as the population ages
  • Dermatologists and Mohs surgeons are facing increasing competition
  • Reimbursement cuts continue to squeeze margins and add pressure on Dermatology practices and physician compensation
  • Dermatology practices and physicians are looking for new ways to:
    • Improve patient satisfaction and outcomes
    • Differentiate within their markets
    • Increase practice and physician revenue and income
    • Maintain a viable, independent practice

SRT is revolutionizing skin cancer
treatment in a dermatological settinG

  • Superficial Radiation Therapy (SRT) has evolved into multi-energy offerings with ultrasound-based, image-guided field placement and tumor volume analysis.
  • SRT is faster. Treatments are completed in as little as one month over 20 fractions—over 40% fewer treatments than in cancer centers.
  • Treatments are well tolerated by patients. There is no pain, scarring or the need to stop blood thinners. Daily doses range from 250–280cGy, which is very well tolerated, including in the lower extremities.
  • Outstanding outcomes. Local control rates for non-melanoma skin cancers are comparable with Mohs micrographic surgery, long considered the “gold standard” in the industry. SRT has the added value of superior cosmesis, no requirement for halting blood thinners, better outcomes for lower extremities, and little to no disruption in daily activities.
  • Patients are seeking out non-invasive solutions. Patients have grown weary of ongoing surgical interventions, are becoming well educated about options, and are looking for alternatives.

Over 95%+ cure rate for non-melanoma skin cancer

HIGH-FREQUENCY ULTRASOUND
IMAGE GUIDANCE SYSTEM
WITH
ULTRA IMPRESSIVE ENHANCEMENTS

The SRT-100 Vision™ has many unique features that make treatment safe, comfortable and effective for patients.

  • Laser Positioning System – For precise beam port positioning and repositioning on the treatment area
  • LesionCam™ – Provides lesion photo-registration and a video of treatment for patient records
  • Touch-Screen Control Console and Control Module – Facilitates the set-up, initiation, monitoring and termination of exposures
  • Audio/Visual Monitor Provides constant bi-directional patient communication
  • Automatic Al and CU Milter magazine – Applies the correct filter to match the selected energy and beam depth
  • Electronic Medical Records (EMR), HL7 and PDF Record and Report Export – Organizes patient scheduling and record management to optimize workflow
  • Dosimetry – Record and Verify  – Calculates proper dosing and measures each dose administered during treatment to ensure patient safety and optimal outcomes
  • RADCheck™ QC – Automatically confirms system calibration each time the system is initiated to ensure the patient is receiving the correct dose and eliminates the need for unscheduled calibrations

Patient Outcomes

Basal Cell Carcinoma

Treatment Field

DAY OF FINAL TREATMENT

AT FOLLOW-UP

Squamous Cell Carcinoma

DAY OF BIOPSY

PATHOLOGY

DAY OF FINAL TREATMENT

AT FOLLOW-UP

Squamous Cell CARCINOMA

Treatment Field

DAY OF FINAL TREATMENT

AT FOLLOW-UP

  • "Joining the SkinCure Oncology team has really opened my eyes to the numerous ways technology can help optimize patient satisfaction and outcomes. As a Mohs surgeon, I know firsthand that many skin cancer patients would prefer a non-invasive alternative. The support staff that SkinCure Oncology provides has been a pleasure to work with, and has improved access to care for my patients."

    Dr. Ladd Jr.

  • "The SkinCure Oncology team has exceeded my expectations in every way. Since adding the SRT capabilities, we’ve been able to expand our treatment protocols to better serve our current patients as well as acquire new ones."

    Dr. Brown

  • "We’re an extremely patient-focused group. Recommending the optimal solution for our patients' dermatology needs is our number one priority. Based on our initial interactions with SkinCure, as well as feedback from our patients, we’re expanding the SRT program to additional locations."

    Dr. Desai